The American Association for Cancer Research (AACR) 2024 Annual Meeting is being held in San Diego and Moores Cancer Center is a proud sponsor of AACR’s Biomedical Career Fair.
Our Marcomms team is looking to compile a list of our division’s presenters: posters, abstracts, plenary sessions, and program chair people who will be giving comments or welcomes to socialize amongst our MCC members. Let us know about the sessions you’ll be attending by filling out the Google Form below:
|
SAVE THE DATE | Moores Cancer Center Delivering Discoveries Scientific Retreat |
September 4th, 2024 | 7:30 a.m. to 6:00 p.m. |
Organizers:
Silvio Gutkind, PhD, Chair
Elena Martinez, PhD, Co-chair
Rana McKay, MD, Co-chair
Mark Garcia, Co-chair
Angela Ballantyne, PhD, Co-chair
|
|
|
February 21, 2024 | 12:00 p.m.
Comer Commons
|
February 22, 2024 | 12:00 p.m.
Comer Commons
|
February 27, 2024 | 12:00 p.m.
Leichtag Biomedical Research Building Room 107
|
March 27, 2024 | 12:00 p.m.
Goldberg Auditorium
|
|
|
Surgical Oncologists As Scientists (SOAS) Training Program |
As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors.
Applications must be submitted by March 1, 2024.
|
Dr. Maryam Ahmadian Memorial Summer Fellowship Program |
Summer research fellowships are available in Metabolic Disease for deserving and committed UCSD undergraduates focused on obesity, diabetes, and related disorders. Ten week stipends will be available for selected candidates to work in laboratories at UCSD or the Salk Institute led by principal investigators who are members in good standing of the UCSD Diabetes Research Center. Applications are due on March 1, 2024, and should be emailed to saltieladmin@health.ucsd.edu
|
Cancer Therapeutics Training (CT2) Training Program |
The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment.
Applications must be submitted by March 15, 2024.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
A Breath of Hope Lung Foundation (ABOHLF) will provide funding to an early career investigator in the form of a $150,000 award paid every six months for two years. Lung cancer is the deadliest cancer killing approximately 130,000 Americans each year, yet research funding support remains disproportionately low per cancer death. Through ABOHLF early-career investigator awards, ABOH ensures that excellent research receives funding and the chosen research institutions have the resources needed to retain promising scientists committed to reducing lung cancer mortality.
Deadline: March 1, 2024
|
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Amount awarded is $3,000,000 disbursed over a 3-year term.
LOI Due: March 12th, 2024
|
The Reach Grant seeks to remove one of these barriers by providing support for important pre-clinical hypothesis-driven research projects that are necessary to move a study from the pre- clinical arena into a clinical trial. The goal of this award is to support translational studies that will result in a phase 1 and/or 2 clinical trial, two to three years from the project end date. The requested budget should be in proportion to the scope of the proposed project and should be for direct costs of $250,000 USD or below over 2 years. A maximum of $125,000 in total direct costs may be requested per year.
Full Proposal Due: March 25, 2024
|
This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic, clinical, or epidemiological cancer research. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Next Deadline: April 1, 2024
|
|
|
| Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion |
Gene Yeo, PhD (Structural and Functional Genomics)
|
|
|
|
|
Cancer mutations converge on a collection of protein assemblies to predict resistance to replication stress |
Xiaoyu Zhao, PhD (Structural and Functional Genomics), Trey Ideker, PhD (Structural and Functional Genomics)
|
|
|
|
|
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma |
Andrew Lowy, MD (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
CO44668: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma | PI: Adam Burgoyne, MD, PhD
NCT: NCT05904886
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
|
|
10th Annual San Diego Colorectal Cancer Screening Roundtable |
February 27, 2024 | 12:00 p.m. to 1:30 p.m. |
Mark your calendars for Tuesday, February 27th, from 12:00 PM to 1:30 PM, as the UC San Diego Moores Cancer Center and its partners commemorate a decade of strides in the fight against colorectal cancer during their 10th Annual Colorectal Cancer Screening Roundtable! Register today to gain insights into the latest trends, screening data, policy updates, and best practices aimed at boosting colorectal cancer screening rates and saving lives. We hope to see you there!
Register Now
|
Make SD HPV Cancer Free 2024 Virtual Summit |
March 4, 2024 | 10:00 to 11:30 a.m. |
You’re invited to our 4th Annual Make SD HPV Cancer Free Summit on Monday, March 4th from 10-11:30am! Join us for updates on HPV vaccination rates, HPV cancer trends, and best practices, strategies and case studies for improving HPV cancer prevention in our community.
|
|
|
EQUITY, DIVERSITY AND INCLUSION (EDI) |
Honoring Black Excellence |
Celebrate Black History Month with us as we recognize the remarkable contributions of the Black community to society and the field of health and science. Join us in honoring the legacies of Drs. Worta McCaskill-Stevens and Edith P. Mitchell, champions of diversity and leaders in cancer research. Click here
to read the full message and learn about upcoming events at NIH to continue the celebration and education. Together, let's commit to fostering inclusivity and equity for all.
Learn More
|
Spring 2024 Faculty Writing Retreat
|
March 25 - 26, 2024 | 9:00 a.m. to 4:00 p.m. |
Make progress on writing projects in a supportive community with other faculty! This 2-day retreat is organized by the Center for Faculty Diversity and Inclusion and facilitated by Chrissy Sharp, Director of Writing and Communication Learning Services at the Commons. Enrollment in the retreat includes facilitation, meals, optional writing consults, and support for dependent care. Applications are due on February 20, 2024.
Apply Now
|
Health Justice, Equity, Diversity, and Inclusion (JEDI) Town Hall |
February 27, 2024 | 12:00 to 1:00 p.m. |
Join us for our first Health Justice, Equity, Diversity, and Inclusion (JEDI) Town Hall on Tuesday, February 27, from Noon to 1 p.m. We will share the department’s journey over the past two years, including our vision, mission, strategic goals, and current key initiatives.
Zoom link: https://uchealth.zoom.us/j/89569847588
Password: healthjedi – all lowercase and no spaces
|
|
|
|
